MENU
Articles by #hashtag

pharmaceuticalindustry

17 hits

'Cancer & Work: Acting Together' at Sanofi

D&T
Mar 13, 2024

The pharmaceutical company Sanofi launched its international program "Cancer & Work: Acting Together" in February. It provides support to employees affected by cancer. The company says in a statement that it is providing social, mental and financial support, with up to twelve months of supplementary pay through a health fund, regardless of job title or […]

Richter Acquires HELM’s Stakes in German Joint Ventures

D&T
Mar 6, 2024

Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has signed an agreement with HELM AG, a Germany-based stock corporation (“HELM”) to buy 50% stake in Richter-Helm BioTec GmbH & Co. KG (“RHT”); and 30% stake in Richter-Helm BioLogics GmbH & Co. KG. (“RHB”) to become 100% owner of […]

Richter and Mithra Commercialize Drug in China

D&T
Dec 4, 2023

The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it expanded its partnership with Mithra Pharmaceuticals SA with a binding Head of Terms (HoT) agreement for the development and commercialization of the first estetrolbased combined oral contraceptive (15 mg estetrol (E4) / 3 mg drospirenone) and […]

Hungaropharma Expands Warehouse Capacity

D&T
Oct 26, 2023

With an investment of HUF 6.2 billion, the most modern pharmaceutical wholesale warehouse in Central and Eastern Europe has been built on 3,000 square meters as the automated high-bay warehouse of Hungaropharma Plc. has been inaugurated The third stage of Hungaropharma's Budapest Logistics Center is not only suitable for the logistics of its own stocks […]

For Personalized and Sustainable Healthcare

D&T
Sep 21, 2023

The Swiss multinational healthcare company Roche, one of the largest pharmaceutical companies in the world by revenue and the leading provider of cancer treatments globally, has diversified activities in Hungary: the pharmaceutical, diagnostics and diabetes divisions and the Roche Service&Solution Center employ over 2,000 people altogether. General Manager Raffaella Claudia Bondi, who has been at […]

Addressing Unmet Patient Needs

D&T
Sep 20, 2023

The Novartis Group has been present in Hungary for more than 25 years. Country President Matt Zeller, the head of its local subsidiary, Novartis Hungary Ltd. elaborates to Diplomacy&Trade on the company’s activities on the Hungarian market with special regard to medical research and development (R&D), an area where the Group is a leading global […]

Richter and Mithra Sign Supply Agreement

D&T
Aug 8, 2023

The Hungarian pharma company Gedeon Richter Plc. and Mithra Pharmaceuticals of Belgium have signed a binding supply agreement for the active pharmaceutical ingredient (API) for the combined oral contraceptive Estelle® and Donesta®, a novel product candidate for the treatment of post-menopausal symptoms. The agreement, announced on the website of the Budapest Stock Exchange, specifies that […]

Richter's Revenue Increased, Profit Decreased

D&T
Aug 4, 2023

In the second quarter of this year, Gedeon RichterPlc. achieved a profit after tax of HUF 30.0 billion, 61.1% below the same period last year, in line with analysts' expectations, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Friday. Total revenue for the quarter was HUF 203.78 billion, up […]

Gedeon Richter Purchases Dutch Firm

D&T
Jul 20, 2023

The Hungarian pharmaceutical company Gedeon Richter Plc. and the Dutch IQ Medical Ventures B.V. have announced on the website of the Budapest Stock Exchange that they signed a Share Purchase Agreement to transfer 100% of the shares of Giskit MD B.V. to Richter from Giskit Holding B.V., the affiliate of IQ Medical. Giskit MD B.V. […]

Vaccines for the World from Gödöllő

D&T
Jul 4, 2023

GSK (formerly GlaxoSmithKline) Plc. is a British multinational biopharma company, one of the top pharma firms in the world. Its plant in Gödöllő, just east of Budapest, has been developed into a strategic actor in GSK’s global vaccine production. The histories of the founders of GSK date back well over a century (in fact, Glaxo's […]

Budapest University Cooperates with Japanese Company

D&T
Jun 29, 2023

The Eötvös Loránd University (ELTE) of Budapest and the Japanese instrument manufacturer JASCO Corporation have signed an agreement aimed at the development of the pharmaceutical industry, it was announced at the event of the University's Innovation Center's Territorial Innovation Platform (TIP) in the Hungarian capital on Thursday. Balázs Hankó, Minister of State for Innovation and […]

New Samyang Biopharm Plant in Gödöllő

D&T
Jun 14, 2023

Korean-owned Samyang Biopharm’s new plant built for EUR 26.2 million has been inaugurated in Gödöllő where synthetic suture materials are manufactured. The company plans to ramp up production gradually, and it will create 55 jobs. South Korean Samyang Group has been present in Hungary since 2010 when Samyang EP Magyarország Kft. started to manufacture plastic […]

Gedeon Richter Reports Increased Profits

D&T
May 12, 2023

Quarterly operating profit growth was 10.1% without FX effects driven by favorable changes in the product portfolio mix and a relatively slower increase of operating expenses, the pharma company Gedeon Richter reports. In addition, no windfall tax was recorded in 2022 Q1. Excluding FX effects Richter’s gross profit increased by 15.3%, driven by a 17.4% […]

New Regional R&Đ Center by Novartis

D&T
May 6, 2023

Swiss-owned pharma company Novartis expands its Hungarian presence by adding a regional R&D center. Apart from its core research functions, the facility will play a crucial role in coordinating related activities in several countries. Having a tradition of over 250 years, the establishment of Novartis’ Hungarian operation dates back to the early nineties. As part […]

Gedeon Richter: Q4 Loss and Competitive Disadvantage

D&T
Feb 28, 2023

The Hungarian pharmaceutical company Gedeon Richter Plc. presented its results for the year 2022 this Tuesday. The report caused a price drop on the stock market, as it turned out that the always massively profitable company turned loss-making in the last quarter of the year (due to the special tax and the exchange rate change). […]

© Copyright 2024 Duax Kft. –  All rights reserved.
sun